About
Company Management
Board of Directors
Scientific Advisory Board
Timeline
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Blog Posts
Media Coverage
Events
Videos
Email Alerts
Contact
About
Company Management
Board of Directors
Scientific Advisory Board
Timeline
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Blog Posts
Media Coverage
Events
Videos
Email Alerts
Contact
© 2020 © 2020 Genprex Inc. All Rights Reserved.
Search Results for:
{search_term_string}
No results for your search.
Search for:
Categories
Blog Posts
Media Coverage
Press Releases
Recent Posts
In pharma, cancer is king
Highlighting Genprex’s Medical Advisors on National Doctors’ Day
Genprex Bolsters Board of Directors, Appoints Three Biotechnology and Healthcare Industry Leaders
Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives
Lead Researcher Behind Genprex’s Diabetes Gene Therapy Featured in New Video Interview
Archives
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
October 2017
July 2017
April 2017
March 2017
January 2017
December 2016
November 2016
August 2016
May 2014
April 2012
September 2011
July 2011
June 2011
April 2011
May 2010
